Valeant Pharmaceuticals ousts CEO Mike Pearson, announces search for new leader | Healthcare Finance News
Valeant hands ex-chief more than $10m payout | Financial Times
Valeant says CEO J. Michael Pearson hospitalized with severe pneumonia | Reuters.com
Mike Pearson Back From Medical Leave
Michael "Mike" Pearson, chairman and chief executive officer of... News Photo - Getty Images
Why the Fall of Valeant Pharmaceuticals' CEO Is Good for You
/https://www.thestar.com/content/dam/thestar/business/2016/01/25/timing-of-valeant-ceo-michael-pearsons-return-from-pneumonia-uncertain/michael-pearsonjpg.jpg "Valeant's congressional hearings into drug pricing delayed; CEO uncertain when he will return | The Star")
Valeant's congressional hearings into drug pricing delayed; CEO uncertain when he will return | The Star
Valeant CEO gives $15M to Duke nursing school - Triangle Business Journal
Valeant's Michael Pearson Admits Aggressive Drug-Price Increases Were a Mistake - WSJ
How Valeant became Canada's hottest stock - The Globe and Mail
Valeant Ex-CEO Pearson Sues Drugmaker Over Withheld Shares - Bloomberg
Valeant's Michael Pearson Admits Aggressive Drug-Price Increases Were a Mistake - WSJ
How Mike Pearson Should Manage His Remaining Time As CEO
Valeant CEO resigns over drug company's 'improper' financial conduct | Pharmaceuticals industry | The Guardian
CEO of the Year 2015: Mike Pearson, Valeant
Valeant CEO Joseph Papa on why that toxic name — and legacy — has to go - The Globe and Mail
J. Michael Pearson, Chief Executive Officer, Valeant Pharmaceuticals International, Inc; gives testimony before the United States Senate Committee on Aging hearing on “Valeant Pharmaceuticals' Business Model: the Repercussions for Patients and the
Valeant CEO Mike Pearson Feeling Better, But May Not Come Back to Work | Fortune
Valeant CEO Mike Pearson will step down - The Boston Globe
Valeant Accidentally Gives CEO Stock
Valeant CEO Mike Pearson swallows the bitter pill of resignation | The World Weekly
Former Valeant CEO suing company over unpaid shares | CBC News
Warren Buffett: Don't run a company like Michael Pearson ran Valeant
Valeant Pharmaceuticals CEO J. Michael Pearson to step down | Globalnews.ca
Valeant CEO Mike Pearson on Medical Leave
Valeant CEO Pearson leaving the company
How Valeant challenged convention—for better, then for worse
